Mark C. Kelley

Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

Hubing Shi, Willy Hugo, Xiangju Kong et al. · Cancer Discovery · 2013 · 986 citations · Full text

Medicine, Genetics, Oncology +17

Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy

Daniel Shae, Kyle W. Becker, Plamen P. Christov et al. · Nature Nanotechnology · 2019 · 657 citations

Medicine, Cancer Biology, Oncology +12

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado et al. · Nature Communications · 2016 · 572 citations · Full text

Life Sciences, Immunology, Oncology +17

Prospective Observational Study of Sentinel Lymphadenectomy Without Further Axillary Dissection in Patients With Sentinel Node–Negative Breast Cancer

Armando E. Giuliano, Philip I. Haigh, Meghan B. Brennan et al. · Journal of Clinical Oncology · 2000 · 557 citations

Medicine, Oncology, Surgery +17

Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results

Thomas E. Yankeelov, Martin Lepage, Anuradha Chakravarthy et al. · Magnetic Resonance Imaging · 2006 · 315 citations · Full text

Medicine, Oncology, Radiology +15